Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Student-directed interactive animation for learning cytochrome P450-mediated drug metabolism.

Doyle J, Glass KC, Racz M, Teng J.

Curr Pharm Teach Learn. 2018 Dec;10(12):1565-1573. doi: 10.1016/j.cptl.2018.08.021. Epub 2018 Oct 1.

PMID:
30527821
2.

Disulfide bridge formation influences ligand recognition by the ATAD2 bromodomain.

Gay JC, Eckenroth BE, Evans CM, Langini C, Carlson S, Lloyd JT, Caflisch A, Glass KC.

Proteins. 2019 Feb;87(2):157-167. doi: 10.1002/prot.25636. Epub 2018 Dec 27.

PMID:
30520161
3.

Biological function and histone recognition of family IV bromodomain-containing proteins.

Lloyd JT, Glass KC.

J Cell Physiol. 2018 Mar;233(3):1877-1886. doi: 10.1002/jcp.26010. Epub 2017 Jun 13. Review.

4.

Mechanism of Histone H3K4me3 Recognition by the Plant Homeodomain of Inhibitor of Growth 3.

Kim S, Natesan S, Cornilescu G, Carlson S, Tonelli M, McClurg UL, Binda O, Robson CN, Markley JL, Balaz S, Glass KC.

J Biol Chem. 2016 Aug 26;291(35):18326-41. doi: 10.1074/jbc.M115.690651. Epub 2016 Jun 8.

5.

Crystallization and preliminary X-ray diffraction analysis of the BRPF1 bromodomain in complex with its H2AK5ac and H4K12ac histone-peptide ligands.

Lubula MY, Poplawaski A, Glass KC.

Acta Crystallogr F Struct Biol Commun. 2014 Oct;70(Pt 10):1389-93. doi: 10.1107/S2053230X14018433. Epub 2014 Sep 25.

6.

Structural insights into recognition of acetylated histone ligands by the BRPF1 bromodomain.

Lubula MY, Eckenroth BE, Carlson S, Poplawski A, Chruszcz M, Glass KC.

FEBS Lett. 2014 Nov 3;588(21):3844-54. doi: 10.1016/j.febslet.2014.09.028. Epub 2014 Sep 30.

7.

Curcumin and dimethoxycurcumin induced epigenetic changes in leukemia cells.

Hassan HE, Carlson S, Abdallah I, Buttolph T, Glass KC, Fandy TE.

Pharm Res. 2015 Mar;32(3):863-75. doi: 10.1007/s11095-014-1502-4. Epub 2014 Sep 4.

PMID:
25186441
8.

The MOZ histone acetyltransferase in epigenetic signaling and disease.

Carlson S, Glass KC.

J Cell Physiol. 2014 Nov;229(11):1571-4. doi: 10.1002/jcp.24617. Review.

9.

Molecular insights into the recognition of N-terminal histone modifications by the BRPF1 bromodomain.

Poplawski A, Hu K, Lee W, Natesan S, Peng D, Carlson S, Shi X, Balaz S, Markley JL, Glass KC.

J Mol Biol. 2014 Apr 17;426(8):1661-76. doi: 10.1016/j.jmb.2013.12.007. Epub 2013 Dec 12.

10.

Fast automated protein NMR data collection and assignment by ADAPT-NMR on Bruker spectrometers.

Lee W, Hu K, Tonelli M, Bahrami A, Neuhardt E, Glass KC, Markley JL.

J Magn Reson. 2013 Nov;236:83-8. doi: 10.1016/j.jmr.2013.08.010. Epub 2013 Aug 30.

11.

Exchange of associated factors directs a switch in HBO1 acetyltransferase histone tail specificity.

Lalonde ME, Avvakumov N, Glass KC, Joncas FH, Saksouk N, Holliday M, Paquet E, Yan K, Tong Q, Klein BJ, Tan S, Yang XJ, Kutateladze TG, Côté J.

Genes Dev. 2013 Sep 15;27(18):2009-24. doi: 10.1101/gad.223396.113.

12.

The limitations of language: male participants, stoicism, and the qualitative research interview.

Affleck W, Glass K, Macdonald ME.

Am J Mens Health. 2013 Mar;7(2):155-62. doi: 10.1177/1557988312464038. Epub 2012 Oct 22.

PMID:
23093076
13.

Histone H3R2 symmetric dimethylation and histone H3K4 trimethylation are tightly correlated in eukaryotic genomes.

Yuan CC, Matthews AG, Jin Y, Chen CF, Chapman BA, Ohsumi TK, Glass KC, Kutateladze TG, Borowsky ML, Struhl K, Oettinger MA.

Cell Rep. 2012 Feb 23;1(2):83-90.

14.

Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation.

Avvakumov N, Lalonde ME, Saksouk N, Paquet E, Glass KC, Landry AJ, Doyon Y, Cayrou C, Robitaille GA, Richard DE, Yang XJ, Kutateladze TG, Côté J.

Mol Cell Biol. 2012 Feb;32(3):689-703. doi: 10.1128/MCB.06455-11. Epub 2011 Dec 5.

15.

Comment on "Multidimensional results reporting to participants in genomic studies: getting it right".

Bookman EB, Langehorne AA, Eckfeldt JH, Glass KC, Jarvik GP, Klag M, Koski G, Motulsky A, Wilfond B, Manolio TA, Fabsitz RR, Luepker RV.

Sci Transl Med. 2011 Feb 16;3(70):70le1. doi: 10.1126/scitranslmed.3001516.

16.

The research imperative revisited: considerations for advancing the debate surrounding medical research as moral imperative.

Wayne K, Glass KC.

Perspect Biol Med. 2010 Summer;53(3):373-87. doi: 10.1353/pbm.0.0173.

PMID:
20639606
17.

Substituting placebo for established, effective therapy: why not?

Shapiro S, Fergusson D, Glass KC.

CMAJ. 2010 Nov 9;182(16):1749-53. doi: 10.1503/cmaj.090548. Epub 2010 Jun 14. Review. No abstract available.

18.

Molecular mechanism of MLL PHD3 and RNA recognition by the Cyp33 RRM domain.

Hom RA, Chang PY, Roy S, Musselman CA, Glass KC, Selezneva AI, Gozani O, Ismagilov RF, Cleary ML, Kutateladze TG.

J Mol Biol. 2010 Jul 9;400(2):145-54. doi: 10.1016/j.jmb.2010.04.067. Epub 2010 May 8.

19.

Structural insight into p53 recognition by the 53BP1 tandem Tudor domain.

Roy S, Musselman CA, Kachirskaia I, Hayashi R, Glass KC, Nix JC, Gozani O, Appella E, Kutateladze TG.

J Mol Biol. 2010 May 14;398(4):489-96. doi: 10.1016/j.jmb.2010.03.024. Epub 2010 Mar 20.

20.

Luminescence variations in hydroxyapatites doped with Eu2+ and Eu3+ ions.

Graeve OA, Kanakala R, Madadi A, Williams BC, Glass KC.

Biomaterials. 2010 May;31(15):4259-67. doi: 10.1016/j.biomaterials.2010.02.009. Epub 2010 Feb 25.

PMID:
20188413
21.

Rethinking risk in pediatric research.

Glass KC, Binik A.

J Law Med Ethics. 2008 Fall;36(3):567-76. doi: 10.1111/j.1748-720X.2008.305.x.

PMID:
18840250
22.

Rebuttal to Dr Streiner: can the "evil" in the "lesser of 2 evils" be justified in placebo-controlled trials?

Glass KC.

Can J Psychiatry. 2008 Jul;53(7):433, discussion 434. No abstract available.

PMID:
18674399
23.

Ethical obligations and the use of placebo controls.

Glass KC.

Can J Psychiatry. 2008 Jul;53(7):428-9. No abstract available.

PMID:
18674397
24.

Decisional challenges for children requiring assisted ventilation at home.

Glass KC, Carnevale FA.

HEC Forum. 2006 Sep;18(3):207-21. No abstract available.

PMID:
17650760
25.

Research Ethics Review and Aboriginal Community Values: Can the Two be Reconciled?

Glass KC, Kaufert J.

J Empir Res Hum Res Ethics. 2007 Jun;2(2):25-40. doi: 10.1525/jer.2007.2.2.25.

PMID:
19385793
26.

Reporting genetic results in research studies: summary and recommendations of an NHLBI working group.

Bookman EB, Langehorne AA, Eckfeldt JH, Glass KC, Jarvik GP, Klag M, Koski G, Motulsky A, Wilfond B, Manolio TA, Fabsitz RR, Luepker RV; NHLBI Working Group.

Am J Med Genet A. 2006 May 15;140(10):1033-40.

27.

Stem cell trials: lessons from gene transfer research.

Kimmelman J, Baylis F, Glass KC.

Hastings Cent Rep. 2006 Jan-Feb;36(1):23-6. No abstract available.

PMID:
16544835
28.

Protection of human subjects and scientific progress: can the two be reconciled?

Glass KC.

Hastings Cent Rep. 2006 Jan-Feb;36(1):4; author reply 8-9. No abstract available.

PMID:
16544824
29.
30.

Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?

Fergusson D, Glass KC, Hutton B, Shapiro S.

Clin Trials. 2005;2(3):218-29; discussion 229-32.

PMID:
16279145
31.

The physician/investigator's obligation to patients participating in research: the case of placebo controlled trials.

Glass KC, Waring D.

J Law Med Ethics. 2005 Fall;33(3):575-85. No abstract available.

PMID:
16240737
32.

Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials.

Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B.

BMJ. 2005 Feb 19;330(7488):396. Review. Erratum in: BMJ. 2005 Mar 19;330(7492):653.

34.

CIOMS' placebo rule and the promotion of negligent medical practice.

Lemmens T, Sprumont D, Nys H, Singh J, Glass KC.

Eur J Health Law. 2004 Jun;11(2):153-74. Review. No abstract available.

PMID:
15387423
35.
36.

Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.

Fergusson D, Glass KC, Waring D, Shapiro S.

BMJ. 2004 Feb 21;328(7437):432. Epub 2004 Jan 22. Review.

37.

Clinical equipoise and the therapeutic misconception.

Glass KC.

Hastings Cent Rep. 2003 Sep-Oct;33(5):5-6; author reply 6. No abstract available.

PMID:
14696271
38.

Effective trial design need not conflict with good patient care.

Glass KC, Waring D.

Am J Bioeth. 2002 Spring;2(2):25-6. No abstract available.

PMID:
12189068
39.

Science and society: children and incompetent adults in genetic research: consent and safeguards.

Knoppers BM, Avard D, Cardinal G, Glass KC.

Nat Rev Genet. 2002 Mar;3(3):221-5. Review.

PMID:
11972159
40.

Ethical issues in neonatal intensive care: perspectives for the neurologist.

Glass KC.

Semin Pediatr Neurol. 2002 Mar;9(1):35-40.

PMID:
11931124
41.

The ethics of placebo-controlled trials.

Weijer C, Glass KC.

N Engl J Med. 2002 Jan 31;346(5):382-3. No abstract available.

PMID:
11821525
42.

Describing our "humanness": can genetic science alter what it means to be "human"

Campbell A, Glass KC, Charland LC.

Sci Eng Ethics. 1998 Oct;4(4):413-26. No abstract available.

PMID:
11658055
43.

Structuring the review of human genetics protocols, part III: gene therapy studies.

Glass KC, Weijer C, Cournoyer D, Lemmens T, Palmour RM, Shapiro SH, Freedman B.

IRB. 1999 Mar-Apr;21(2):1-9. No abstract available.

PMID:
11657874
44.

Dialog on genetic catastrophe.

Solyagua C, Kennedy GE, Sobiezek RA, Glass KC, Needleman J.

West J Med. 2001 Sep;175(3):174-83. No abstract available.

45.

Human genetic research, DNA banking and consent: a question of 'form'?

Deschênes M, Cardinal G, Knoppers BM, Glass KC.

Clin Genet. 2001 Apr;59(4):221-39. Review. No abstract available.

PMID:
11298677
46.

Ethical issues of human germ-cell therapy: a preparation for public discussion.

Szebik I, Glass KC.

Acad Med. 2001 Jan;76(1):32-8.

PMID:
11154190
47.

Why Sackett's analysis of randomized controlled trials fails, but needn't.

Shapiro SH, Glass KC.

CMAJ. 2000 Oct 3;163(7):834-5. No abstract available.

48.

Policy forum: genetic technologies. Commercialization of genetic research and public policy.

Knoppers BM, Hirtle M, Glass KC.

Science. 1999 Dec 17;286(5448):2277-8. No abstract available. Erratum in: Science 2000 Jan 7;287(5450):43.

PMID:
10636788
49.

Structuring the review of human genetics protocols, Part II: diagnostic and screening studies.

Glass KC, Weijer C, Lemmens T, Palmour RM, Shapiro SH.

IRB. 1997 May-Aug;19(3-4):1-13. No abstract available.

PMID:
11656943
50.

Bioethics for clinicians: 7. Truth telling.

Hébert PC, Hoffmaster B, Glass KC, Singer PA.

CMAJ. 1997 Jan 15;156(2):225-8.

Supplemental Content

Loading ...
Support Center